# Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

> **NCT00948818** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 803 (actual)

## Conditions studied

- Irritable Bowel Syndrome Characterized by Constipation

## Interventions

- **DRUG:** Linaclotide 290 micrograms
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT00948818
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-08
- **Target enrollment:** 803 (ACTUAL)
- **Last updated:** 2013-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00948818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00948818, "Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00948818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*